Tweet
NEW MEXICO DEPARTMENT OF HEALTH
"FOR IMMEDIATE RELEASE:
Contact: David Morgan
May 24, 2013
Office: (575) 528-5197
Cell: (575) 649-0754
New Mexico Health Officials Investigating Product Used in Roswell Clinic
(Santa Fe) ? The New Mexico Department of Health is participating with other local, state and federal health agencies in an investigation of products prepared by a drug manufacturer and used at medical clinics around the United States.
New Mexico is one of 13 states with at least one clinic receiving the product. New Mexico?s one clinic is in Roswell, Roswell Family Care, where the drug is no longer in use.
The Department of Health is already working with the clinic in Roswell to get a list of patients who received the product and assure that the patients are contacted to advise them of precautions and assure none have had any illness.
The drug is methylprednisolone acetate (MPA) and is used to treat inflammation and reactive airways disease. To date, the U.S. Food and Drug Administration has received seven reports of illness related to the MPA?all of them in North Carolina and Illinois. There are no reports of any adverse events associated with use of these products in New Mexico.
The only adverse events identified in North Carolina and Illinois thus far are skin abscesses abscesses at the site of injection.
The drug was produced by Main Street Family Pharmacy, LLC, in Newbern, Tennessee. The company has recently issued a recall of its entire stock of sterile products (including MPA) manufactured after Dec. 6, 2012."
xhttp://www.health.state.nm.us/CommunicationsOffice/2013%20News%20Releases/NMDOH-PressRelease-20130524-InvestigatingDentalProduct-EN.pdf
"FOR IMMEDIATE RELEASE:
Contact: David Morgan
May 24, 2013
Office: (575) 528-5197
Cell: (575) 649-0754
New Mexico Health Officials Investigating Product Used in Roswell Clinic
(Santa Fe) ? The New Mexico Department of Health is participating with other local, state and federal health agencies in an investigation of products prepared by a drug manufacturer and used at medical clinics around the United States.
New Mexico is one of 13 states with at least one clinic receiving the product. New Mexico?s one clinic is in Roswell, Roswell Family Care, where the drug is no longer in use.
The Department of Health is already working with the clinic in Roswell to get a list of patients who received the product and assure that the patients are contacted to advise them of precautions and assure none have had any illness.
The drug is methylprednisolone acetate (MPA) and is used to treat inflammation and reactive airways disease. To date, the U.S. Food and Drug Administration has received seven reports of illness related to the MPA?all of them in North Carolina and Illinois. There are no reports of any adverse events associated with use of these products in New Mexico.
The only adverse events identified in North Carolina and Illinois thus far are skin abscesses abscesses at the site of injection.
The drug was produced by Main Street Family Pharmacy, LLC, in Newbern, Tennessee. The company has recently issued a recall of its entire stock of sterile products (including MPA) manufactured after Dec. 6, 2012."
xhttp://www.health.state.nm.us/CommunicationsOffice/2013%20News%20Releases/NMDOH-PressRelease-20130524-InvestigatingDentalProduct-EN.pdf
